Session Type: ACR Poster Session C
Session Time: 9:00AM-11:00AM
Background/Purpose: Psoriatic arthritis is a heterogenous disease that can effectively be treated with biologic therapy. The treatment outcome is affected by difference in disease expression and patients population. The aim of this study was to evaluate the patient reported outcome of the therapy and the disease activity in the perspective of gender differences.
Methods: Data on patients with psoriatic arthritis were extracted from the Estonian Society for Rheumatology Biologic Therapy Register from 2008 to 2014. Demographic, clinical and disease activity measurements were evaluated at the initiation of the biologic therapy and at patients last recorded registry entry during the observational period. The association of gender and patient reported outcome measures and objective disease acitivity measures were assessed with Wilcoxon rank-sum test, linear regression was used to adapt for potential confounders.
To cite this abstract in AMA style:Tälli S, Tammaru M, Otsa K. Patient Reported Disease Activity and Efficacy of Biologic Therapy in Patients with Psoriatic Arthritis. an Observational Study of 107 Patients of the Estonian Society for Rheumatology Biologic Therapy Register during 2008-2014 [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/patient-reported-disease-activity-and-efficacy-of-biologic-therapy-in-patients-with-psoriatic-arthritis-an-observational-study-of-107-patients-of-the-estonian-society-for-rheumatology-biologic-therap/. Accessed July 11, 2020.
« Back to 2016 ACR/ARHP Annual Meeting
ACR Meeting Abstracts - https://acrabstracts.org/abstract/patient-reported-disease-activity-and-efficacy-of-biologic-therapy-in-patients-with-psoriatic-arthritis-an-observational-study-of-107-patients-of-the-estonian-society-for-rheumatology-biologic-therap/